INNOVACAP
INNOVACAP
Each stock's 10,000-path forecast, rendered as light.
INNOVACAP (INNOVACAP) Stock Analysis & Case Study
Is INNOVACAP a good buy? The data-driven verdict.
INNOVACAP (INNOVACAP) trades at ₹935,on the numbers it worth a closer look, a Downstox Snapshot Score of 55/100.
On the numbers, INNOVACAP (INNOVACAP) worth a closer look, a Downstox Snapshot Score of 55/100, weighing premium at 38.0× earnings, ROE of 13.7%, a 71% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
INNOVACAP fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
Is INNOVACAP overvalued? INNOVACAP P/E vs its sector
INNOVACAP's P/E of 38.0× sits above the sector peer median of 15.9×, so on earnings it screens richer than peers, while its 0.21% dividend yield is below the peer median of 1.65%.
INNOVACAP share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of INNOVACAP history (33%/yr drift, 42%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| INNOVACAP 2027 | ₹704 | ₹1,200 | ₹2,042 | +26% |
| INNOVACAP 2028 | ₹716 | ₹1,534 | ₹3,242 | +62% |
| INNOVACAP 2029 | ₹766 | ₹1,923 | ₹4,885 | +103% |
| INNOVACAP 2030 | ₹837 | ₹2,461 | ₹7,176 | +159% |
| INNOVACAP 2031 | ₹937 | ₹3,122 | ₹10,304 | +229% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability INNOVACAP goes up, or doubles?
The bull case for INNOVACAP
- A healthy 13.7% return on equity.
- A 10,000-path probability model puts a 71% chance the price is higher in a year, with a median target of ₹1,200 (+26%).
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹4,885.
The bear case & risks
- At 38.0× earnings the stock carries a premium to the market, strong growth is already in the price, so any miss tends to be punished.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹766.
INNOVACAP volatility & expected range, how bumpy is the ride?
Over the last 2.0 years INNOVACAP compounded at 33%/year with annualized volatility of 42%. That volatility implies a 1-year 80% range of ₹704–₹2,042, the honest backbone behind any single price target.
INNOVACAP price forecast, the full 60-month probability fan
INNOVACAP price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds INNOVACAP hits common targets within the simulated horizon?
Full multi-horizon detail on the INNOVACAP price target & forecast page.
INNOVACAP Piotroski F-Score: 4/9, how financially strong is it?
The Piotroski F-Score grades financial strength on nine profitability, leverage and efficiency checks. INNOVACAP scores 4/9,mixed financial health.
INNOVACAP MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy INNOVACAP with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.0% | 2.9× |
| ZerodhaCHEAPEST | 32.7% | 3.1× |
| DhanCHEAPEST | 32.7% | 3.1× |
Compare every broker on the INNOVACAP MTF page.
INNOVACAP vs peers,sector comparison
About INNOVACAP: sector, index & market-cap context
INNOVACAP (INNOVACAP) is a small-cap NSE-listed company, and a constituent of the Nifty 500 index group, with a market capitalisation of ₹5,338 Cr. See more Nifty 500 stocks.
How the INNOVACAP Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of INNOVACAP's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
INNOVACAP analysis, FAQs
Is INNOVACAP (INNOVACAP) a good buy?
On the numbers, INNOVACAP (INNOVACAP) worth a closer look, a Downstox Snapshot Score of 55/100, weighing premium at 38.0× earnings, ROE of 13.7%, a 71% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is INNOVACAP overvalued or undervalued?
INNOVACAP trades at 38.0× earnings versus a peer median of 15.9×, so it screens richer than its sector peers.
What is the INNOVACAP share price target for 2031?
INNOVACAP's probability-weighted 2031 median target is ₹3,122, with an 80% range of ₹937–₹10,304 (10,000-path Monte-Carlo).
What is the probability INNOVACAP doubles in 5 years?
The modelled probability of INNOVACAP reaching ₹1,899 (2×) within 5 years is 70%.
What is the bull case for INNOVACAP?
A healthy 13.7% return on equity. A 10,000-path probability model puts a 71% chance the price is higher in a year, with a median target of ₹1,200 (+26%).
What are the risks in INNOVACAP?
At 38.0× earnings the stock carries a premium to the market, strong growth is already in the price, so any miss tends to be punished.